How to buy BioRestorative Therapies stock

BioRestorative Therapies, a Melvillve, NY-based company that develops stem cell therapies, has applied for listing on the Nasdaq under the ticker symbol "BRTX."

BioRestorative Therapies stock price (NASDAQ: BRTX)

Use our graph to track the performance of BRTX stocks over time.

BioRestorative Therapies shares at a glance

• Key figures

Information last updated 2023-09-17.

Latest market close	$1.60
52-week range	$1.41 - $7.13
50-day moving average more info button	$2.64
200-day moving average more info button	$3.50
Wall St. target price	$12.50
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-5.06

Buy BioRestorative Therapies stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy BioRestorative Therapies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioRestorative Therapies price performance over time

Historical closes compared with the close of $1.6001 from 2023-09-21

1 week (2023-09-15)	-4.19%
1 month (2023-08-22)	-37.25%
3 months (2023-06-22)	-71.17%
6 months (2023-03-22)	-50.61%

1 year (2022-09-22)	-43.46%
2 years (2021-09-22)	-87.50%
3 years (2020-09-22)	63.6
5 years (2018-09-21)	8680

BioRestorative Therapies financials

Revenue TTM	$128,500
Gross profit TTM	$119,800
Return on assets TTM	-69.43%
Return on equity TTM	-114.03%
Profit margin	0%
Book value	$3.11
Market Capitalization more info button	$7.8 million

TTM: trailing 12 months

BioRestorative Therapies share dividends

We're not expecting BioRestorative Therapies to pay a dividend over the next 12 months.

Have BioRestorative Therapies's shares ever split?

BioRestorative Therapies's shares were split on a 1:4000 basis on 27 October 2021. So if you had owned 4000 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioRestorative Therapies shares – just the quantity. However, indirectly, the new 399900% higher share price could have impacted the market appetite for BioRestorative Therapies shares which in turn could have impacted BioRestorative Therapies's share price.

BioRestorative Therapies share price volatility

Over the last 12 months, BioRestorative Therapies's shares have ranged in value from as little as $1.41 up to $7.13. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioRestorative Therapies's is 60.8582. This would suggest that BioRestorative Therapies's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put BioRestorative Therapies's beta into context you can compare it against those of similar companies.

• Plus Therapeutics (PSTV.US): 0.3426
• Athersys (ATHX.US): -0.7358
• Rani Therapeutics (RANI.US): 0.334

BioRestorative Therapies overview

BioRestorative Therapies, Inc. , a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc.

Frequently asked questions

What percentage of BioRestorative Therapies is owned by insiders or institutions?
Currently 18.928% of BioRestorative Therapies shares are held by insiders and 16.823% by institutions. How many people work for BioRestorative Therapies?
Latest data suggests 10 work at BioRestorative Therapies. When does the fiscal year end for BioRestorative Therapies?
BioRestorative Therapies's fiscal year ends in December. Where is BioRestorative Therapies based?
BioRestorative Therapies's address is: 40 Marcus Drive, Melville, NY, United States, 11747 What is BioRestorative Therapies's ISIN number?
BioRestorative Therapies's international securities identification number is: US0906556065 What is BioRestorative Therapies's CUSIP number?
BioRestorative Therapies's Committee on Uniform Securities Identification Procedures number is: 090655408